Selected article for: "clinical disease and virus exposure"

Author: Kanaan, Abir O.; Sullivan, Karyn M.; Seed, Sheila M.; Cookson, Nathan A.; Spooner, Linda M.; Abraham, George M.
Title: In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital
  • Cord-id: f36jpopy
  • Document date: 2020_11_21
  • ID: f36jpopy
    Snippet: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies
    Document: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies to various case questions, describing some of the challenges faced by practitioners at an urban teaching hospital during the COVID-19 pandemic. The strategies suggested can be explored at other institutions.

    Search related documents:
    Co phrase search for related documents
    • abnormal coagulation and lmwh weight heparin: 1, 2, 3
    • abnormal coagulation and low molecular: 1, 2, 3, 4, 5, 6, 7
    • abnormal coagulation and low molecular lmwh weight heparin: 1, 2, 3
    • accurate reporting and local national: 1
    • acute medical illness and lmwh weight heparin: 1
    • acute medical illness and local national: 1
    • acute medical illness and low molecular: 1
    • acute medical illness and low molecular lmwh weight heparin: 1
    • acutely ill and lmwh thromboprophylaxis: 1, 2
    • acutely ill and lmwh weight heparin: 1, 2, 3
    • acutely ill and low molecular: 1, 2, 3, 4, 5
    • acutely ill and low molecular lmwh weight heparin: 1, 2, 3